This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
Usually when two appropriate medications haven’t controlled seizures.
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
This systematic review examined medium-chain triglyceride (MCT)-based interventions for people with drug-resistant epilepsy.
This nationwide Taiwan study included 2,583,503 people born from 2001 through 2016 and followed through 2021.
This article was a critical review, not a new clinical trial, and the abstract does not report enrolling participants.
This narrative review brought together published research on early infantile developmental and epileptic encephalopathy (EIDEE), a severe epilepsy syndrome beginning before 3 months of age.
This scoping review mapped published research on epilepsy of infancy with migrating focal seizures (EIMFS), a rare and severe epilepsy syndrome beginning in infancy.
This systematic review and meta-analysis compared levetiracetam with sodium valproate in children age 18 or younger with new-onset epilepsy or established status epilepticus.
Researchers combined results from 19 studies involving 3,226 children with epilepsy.
Researchers described co-occurring health conditions in 1,054 children and youth with validated epilepsy diagnoses in Norway.
Researchers analyzed two large, nationally representative U.S.